Skip to main content
Log in

Intraoperative Assessment of Pancreatic Neck Margin at the Time of Pancreaticoduodenectomy Increases Likelihood of Margin-Negative Resection in Patients with Pancreatic Cancer

  • SSAT Poster Presentation
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

The utility of intraoperative assessment of surgical margins is often debated by experienced pancreatic surgeons. We sought to review our experience with pancreaticoduodenectomy (PD) for pancreatic cancer to determine the impact of intraoperative frozen section (FS) analysis on margin-negative resection and long-term outcome.

Material and Methods

Between 1992 and 2007, 310 consecutive patients underwent PD at our institution; 223 of these were for pancreatic cancer. Seven patients who underwent R2 resection were excluded. Charts were reviewed to determine demographics, final pathology, perioperative course, and long-term outcome. Data were compared by Fisher’s exact and Student’s t tests. Survival curves were created using the Kaplan–Meier method and compared by log-rank analysis. Predictors of margin-negative resection were determined by logistic regression analysis and predictors of survival determined by Cox proportional hazards analysis.

Results

FS analysis of pancreatic neck resection margins was obtained in 75, while no intraoperative assessment was done in 141. Although patients who underwent FS were younger (median, 62 vs. 67 years, p = 0.01), the two groups were similar in terms of gender, comorbidities, preoperative stenting, pylorus preservation, tumor differentiation, nodal status, tumor size, length of stay, and complication rate. Margin-negative resection was more common when FS was undertaken (99% vs. 81%, p = 0.0001). However, intraoperative FS did not significantly increase overall survival (median, 21.7 vs. 14.6, p = 0.20). Only nodal metastasis was predictive of poor survival (median, 21.7 vs. 13.3 months, p = 0.001).

Conclusions

Intraoperative assessment of the pancreatic neck margin status at the time of PD for pancreatic cancer increases the likelihood of obtaining a margin-negative resection. Noteworthy is that final margin status was not predictive of survival, while only nodal metastasis was, suggesting that tumor biology is the most important factor in patients with pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer Statistics, 2007. CA Cancer J Clin 2007;57(1):43–66.

    Article  PubMed  Google Scholar 

  2. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997;225(5):621–633. doi:10.1097/00000658-199705000-00018.

    Article  PubMed  CAS  Google Scholar 

  3. Kosuri K, Muscarella P, Bekaii-Saab T. Updates and controversies in the treatment of pancreatic cancer. Clin Adv Hematol Oncol 2006;4(1):47–54.

    PubMed  Google Scholar 

  4. Howard TJ, Krug J, Yu J, Zyromski N, Schmidt CM, Jacobson L, Madura J, Wiebke EA, Lillemoe KA. Margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006;10(10):1338–1345. doi:10.1016/j.gassur.2006.09.008.

    Article  PubMed  Google Scholar 

  5. Forrest JF, Longmire WP Jr. Carcinoma of the pancreas and the periampullary region. Ann Surg 1979;189(2):129–138. doi:10.1097/00000658-197902000-00001.

    Article  PubMed  CAS  Google Scholar 

  6. Schouten JT. Operative therapy for pancreatic carcinoma. Am J Surg 1986;151(5):626–630. doi:10.1016/0002-9610(86)90575-1.

    Article  PubMed  CAS  Google Scholar 

  7. Esposito I, Kleef J, Bergmann F, Reiser C, Herpel E, Helmut F, Schirmacher P, Buchler MW. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008;15(6):1651–1660. doi:10.1245/s10434-008-9839-8.

    Article  PubMed  Google Scholar 

  8. Nitecki SS, Sarr MG, Colby TV, Van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Ann Surg 1995;221:59–66. doi:10.1097/00000658-199501000-00007.

    Article  PubMed  CAS  Google Scholar 

  9. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;94:586–594. doi:10.1002/bjs.4484.

    Article  Google Scholar 

  10. Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, Zhao Q, Howard TJ, Madura JA, Nakeeb A, Pitt HA, Cameron JL, Yeo CJ, Lillemoe KD. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 2007;142(4):572–578. doi:10.1016/j.surg.2007.07.016.

    Article  PubMed  Google Scholar 

  11. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 1996;83:625–631. doi:10.1002/bjs.1800830512.

    Article  PubMed  CAS  Google Scholar 

  12. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas: Implications for radiation therapy. Ann Surg 1993;217:144–148. doi:10.1097/00000658-199302000-00008.

    Article  PubMed  CAS  Google Scholar 

  13. Beger HG, Rau B, Gansauge F, Poch B, Link KH. Treatment of pancreatic cancer: challenge of the facts. World J Surg 2003;27(10):1075–1084. doi:10.1007/s00268-003-7165-7.

    Article  PubMed  Google Scholar 

  14. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Impact of resection status on pattern failure and survival after pancreatiocduodenectomy for pancreatic adenocarcinoma. Ann Surg 2007;246(1):52–60. doi:10.1097/01.sla.0000259391.84304.2b.

    Article  PubMed  Google Scholar 

  15. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Lacaine F, Buckels J, Deakin M, Adab FA, Sutton R, Imrie C, Ihse I, Tihanyi T, Olah A, Pedrazzoli S, Spooner D, Kerr DJ, Friess H, Büchler MW, European Study Group for Pancreatic Cancer. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001;234(6):758–768. doi:10.1097/00000658-200112000-00007.

    Article  PubMed  CAS  Google Scholar 

  16. Verbeke CS. Resection margins and R1 rates in pancreatic cancer—are we there yet? Histopathology 2008;52(7):787–796. doi:10.1111/j.1365-2559.2007.02935.x.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Dr. Bloomston is supported as a Paul Calebresi Scholar on NIH/NCI 1 K12 CA133250-01.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark Bloomston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dillhoff, M., Yates, R., Wall, K. et al. Intraoperative Assessment of Pancreatic Neck Margin at the Time of Pancreaticoduodenectomy Increases Likelihood of Margin-Negative Resection in Patients with Pancreatic Cancer. J Gastrointest Surg 13, 825–830 (2009). https://doi.org/10.1007/s11605-009-0845-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-009-0845-3

Keywords

Navigation